"10.1371_journal.pone.0138776","plos one","2015-09-30T00:00:00Z","Teiji Kuzuya; Masatoshi Ishigami; Yoji Ishizu; Takashi Honda; Kazuhiko Hayashi; Yoshiaki Katano; Yoshiki Hirooka; Tetsuya Ishikawa; Isao Nakano; Hidemi Goto","Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Gastroenterology, Banbuntane Hotokukai Hospital, Fujita Health University, School of Medicine, Nagoya, Japan","Conceived and designed the experiments: TK MI. Performed the experiments: TK MI YI KH TH TI IN. Analyzed the data: TK MI. Contributed reagents/materials/analysis tools: TK MI YK YH HG. Wrote the paper: TK MI HG.","This study was supported by Bayer Yakuhin, Ltd. Sorafenib is co-developed and co-marketed by Bayer. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","09","Teiji Kuzuya","TK",10,TRUE,2,7,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
